Enabling faster therapeutic antibody discovery through an integrated AI/ML-wet lab platform

Enabling faster therapeutic antibody discovery through an integrated AI/ML-wet lab platform

During antibody discovery, researchers characterize and optimize thousands of antibody molecules to select ideal drug candidates. Artificial intelligence/machine learning (AI/ML) technologies provide new opportunities for identifying and generating high-quality antibody drugs in less time.

In this webinar, Charbel Eid, from BigHat Biosciences, will discuss an innovative AI/ML platform that guides antibody design and accelerates the discovery of better antibody therapeutics.

Join this webinar to explore:

  • A novel, integrated AI/ML-wet lab platform
  • How AI/ML enables faster antibody discovery
  • How synthetic biology and IDT’s gene fragments facilitate rapid iteration

Published on: February 01, 2023